Globus Medical, Inc. (GMED)

NYQ – Real Time Price. Currency in USD

84.75

-0.40 (-0.46%)

Market open: Aug 12, 2026, 2:30 PM EDT

86.87

+1.72 (2.01%)

Previous after-hours: Aug 11, 2026, 7:42 PM EDT

08.08.2026

Globus Medical Q2 Earnings Call Highlights

Globus Medical NYSE: GMED reported second-quarter 2026 revenue of $789.6 million, up 6% from a year earlier, as growth in its spine and trauma businesses helped offset declines in enabling technologies and Nevro sales. The company reaffirmed its full-year revenue outlook while raising its adjusted earnings forecast, citing margin expansion and operating leverage in the first half.

07.08.2026

GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution

Globus Medical raises 2026 EPS guidance after Q2 margin gains and spine growth while holding sales guidance steady amid Nevro and Enabling Technologies risks.

07.08.2026

Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

07.08.2026

Globus Medical, Inc. (GMED) Q2 2026 Earnings Call Transcript

07.08.2026

Globus Medical (GMED) Q2 Earnings and Revenues Surpass Estimates

Globus Medical (GMED) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.86 per share a year ago.

06.08.2026

Globus Medical Reports Second Quarter 2026 Results

AUDUBON, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the second quarter ended June 30, 2026.

06.08.2026

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
GMED	UBS	Neutral	undefined >> $82	July 28th 2026

Press releases

06.08.2026

Globus Medical, Inc. (GMED)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Globus Medical, Inc. (GMED)

Globus Medical Q2 Earnings Call Highlights

GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution

Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Globus Medical, Inc. (GMED) Q2 2026 Earnings Call Transcript

Globus Medical (GMED) Q2 Earnings and Revenues Surpass Estimates

Globus Medical Reports Second Quarter 2026 Results

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term

Videos

No Data

Upgrades / Downgrades

Press releases

Globus Medical Reports Second Quarter 2026 Results

Globus Medical Q2 Earnings Call Highlights

GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution

Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Globus Medical, Inc. (GMED) Q2 2026 Earnings Call Transcript

Globus Medical (GMED) Q2 Earnings and Revenues Surpass Estimates

Globus Medical Reports Second Quarter 2026 Results

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term

Videos

No Data

Upgrades / Downgrades

Press releases

Globus Medical Reports Second Quarter 2026 Results

Search stocks

Globus Medical, Inc. (GMED)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Globus Medical, Inc. (GMED)

Globus Medical Q2 Earnings Call Highlights

GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution

Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Globus Medical, Inc. (GMED) Q2 2026 Earnings Call Transcript

Globus Medical (GMED) Q2 Earnings and Revenues Surpass Estimates

Globus Medical Reports Second Quarter 2026 Results

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term

Videos

No Data

Upgrades / Downgrades

Press releases

Globus Medical Reports Second Quarter 2026 Results

Globus Medical Q2 Earnings Call Highlights

GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution

Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Globus Medical, Inc. (GMED) Q2 2026 Earnings Call Transcript

Globus Medical (GMED) Q2 Earnings and Revenues Surpass Estimates

Globus Medical Reports Second Quarter 2026 Results

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term

Videos

No Data

Upgrades / Downgrades

Press releases

Globus Medical Reports Second Quarter 2026 Results